[Skip to Navigation]
Sign In
Figure 1.  Map of Chronic Lower Respiratory Disease (CLRD) Age-Adjusted Hospitalization Rate per 10 000 Population for 62 Counties of New York State, 2016
Map of Chronic Lower Respiratory Disease (CLRD) Age-Adjusted Hospitalization Rate per 10 000 Population for 62 Counties of New York State, 2016
Figure 2.  Map of Chronic Lower Respiratory Disease (CLRD) Age-Adjusted Mortality Rate per 100 000 for 62 Counties of New York State, 2014 to 2016
Map of Chronic Lower Respiratory Disease (CLRD) Age-Adjusted Mortality Rate per 100 000 for 62 Counties of New York State, 2014 to 2016
Figure 3.  Map of 2018 County Health Rankings (CHR) Overall Health Factors z Score for 62 Counties of New York State
Map of 2018 County Health Rankings (CHR) Overall Health Factors z Score for 62 Counties of New York State
Table 1.  Summary of County Health Rankings z Score and Age-Adjusted Hospitalization and Mortality Rate of 62 Counties in New York State
Summary of County Health Rankings z Score and Age-Adjusted Hospitalization and Mortality Rate of 62 Counties in New York State
Table 2.  Linear Regression Analysis of Variables Associated With CLRD Outcomes
Linear Regression Analysis of Variables Associated With CLRD Outcomes
1.
Vestbo  J, Hurd  SS, Agustí  AG,  et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.   Am J Respir Crit Care Med. 2013;187(4):347-365. doi:10.1164/rccm.201204-0596PPPubMedGoogle ScholarCrossref
2.
Postma  DS, Rabe  KF.  The asthma–COPD overlap syndrome.   N Engl J Med. 2015;373(13):1241-1249. doi:10.1056/NEJMra1411863PubMedGoogle ScholarCrossref
3.
Cloutier  MM, Baptist  AP, Blake  KV,  et al; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC).  2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.   J Allergy Clin Immunol. 2020;146(6):1217-1270. doi:10.1016/j.jaci.2020.10.003PubMedGoogle ScholarCrossref
4.
National Heart, Lung, and Blood Institute (NHLBI).  Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung and Blood Diseases. National Institutes of Health; 2012.
5.
Blackwell  DL, Lucas  JW, Clarke  TC.  Summary health statistics for U.S. adults: national health interview survey, 2012.   Vital Health Stat 10. 2014;(260):1-161.PubMedGoogle Scholar
6.
Centers for Disease Control and Prevention. Underlying cause of death, 1999-2019. Accessed October 28, 2021. https://wonder.cdc.gov/ucd-icd10.html
7.
Global Alliance Against Chronic Respiratory Diseases. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Accessed October 28, 2021. https://www.who.int/gard/publications/GARD_Manual/en/
8.
Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Accessed October 28, 2021. https://www.cdc.gov/nchs/icd/icd10cm.htm
9.
Booske  BC, Athens  JK, Kindig  DA, Park  H, Remington  PL.  County Health Rankings Working Paper: Different Perspectives for Assigning Weights to Determinants of Health. University of Wisconsin; 2012.
10.
Remington  PL, Catlin  BB, Gennuso  KP.  The County Health Rankings: rationale and methods.   Popul Health Metr. 2015;13(1):11. doi:10.1186/s12963-015-0044-2PubMedGoogle ScholarCrossref
11.
Pleasants  RA, Riley  IL, Mannino  DM.  Defining and targeting health disparities in chronic obstructive pulmonary disease.   Int J Chron Obstruct Pulmon Dis. 2016;11:2475-2496. doi:10.2147/COPD.S79077PubMedGoogle ScholarCrossref
12.
Prescott  E, Godtfredsen  N, Vestbo  J, Osler  M.  Social position and mortality from respiratory diseases in males and females.   Eur Respir J. 2003;21(5):821-826. doi:10.1183/09031936.03.00047502PubMedGoogle ScholarCrossref
13.
Steenland  K, Hu  S, Walker  J.  All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997.   Am J Public Health. 2004;94(6):1037-1042. doi:10.2105/AJPH.94.6.1037PubMedGoogle ScholarCrossref
14.
Huisman  M, Kunst  AE, Bopp  M,  et al.  Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations.   Lancet. 2005;365(9458):493-500. doi:10.1016/S0140-6736(05)17867-2PubMedGoogle ScholarCrossref
15.
Lewis  DR, Clegg  LX, Johnson  NJ.  Lung disease mortality in the United States: the national longitudinal mortality study.   Int J Tuberc Lung Dis. 2009;13(8):1008-1014.PubMedGoogle Scholar
16.
Gershon  AS, Hwee  J, Victor  JC, Wilton  AS, To  T.  Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease.   Ann Am Thorac Soc. 2014;11(8):1195-1202. doi:10.1513/AnnalsATS.201403-094OCPubMedGoogle ScholarCrossref
17.
Sullivan  K, Thakur  N.  Structural and social determinants of health in asthma in developed economies: a scoping review of literature published between 2014 and 2019.   Curr Allergy Asthma Rep. 2020;20(2):5. doi:10.1007/s11882-020-0899-6PubMedGoogle ScholarCrossref
18.
McLeish  AC, Zvolensky  MJ.  Asthma and cigarette smoking: a review of the empirical literature.   J Asthma. 2010;47(4):345-361. doi:10.3109/02770900903556413PubMedGoogle ScholarCrossref
19.
Polosa  R, Thomson  NC.  Smoking and asthma: dangerous liaisons.   Eur Respir J. 2013;41(3):716-726. doi:10.1183/09031936.00073312PubMedGoogle ScholarCrossref
20.
Godtfredsen  NS, Lam  TH, Hansel  TT,  et al.  COPD-related morbidity and mortality after smoking cessation: status of the evidence.   Eur Respir J. 2008;32(4):844-853. doi:10.1183/09031936.00160007PubMedGoogle ScholarCrossref
21.
Berry  CE, Wise  RA.  Mortality in COPD: causes, risk factors, and prevention.   COPD. 2010;7(5):375-382. doi:10.3109/15412555.2010.510160PubMedGoogle ScholarCrossref
22.
Celli  BR.  Predictors of mortality in COPD.   Respir Med. 2010;104(6):773-779. doi:10.1016/j.rmed.2009.12.017PubMedGoogle ScholarCrossref
23.
Tønnesen  P.  Smoking cessation and COPD.   Eur Respir Rev. 2013;22(127):37-43. doi:10.1183/09059180.00007212PubMedGoogle ScholarCrossref
24.
Trachtenberg  AJ, Dik  N, Chateau  D, Katz  A.  Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a Canadian city.   Ann Fam Med. 2014;12(5):402-407. doi:10.1370/afm.1683PubMedGoogle ScholarCrossref
25.
Calderón-Larrañaga  A, Carney  L, Soljak  M,  et al.  Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England: national cross-sectional study.   Thorax. 2011;66(3):191-196. doi:10.1136/thx.2010.147058PubMedGoogle ScholarCrossref
26.
McAllister  DA, Morling  JR, Fischbacher  CM, MacNee  W, Wild  SH.  Socioeconomic deprivation increases the effect of winter on admissions to hospital with COPD: retrospective analysis of 10 years of national hospitalisation data.   Prim Care Respir J. 2013;22(3):296-299. doi:10.4104/pcrj.2013.00066PubMedGoogle ScholarCrossref
27.
Gupta  RP, Mukherjee  M, Sheikh  A, Strachan  DP.  Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England.   Thorax. 2018;73(8):706-712. doi:10.1136/thoraxjnl-2017-210714PubMedGoogle ScholarCrossref
28.
Keet  CA, Matsui  EC, McCormack  MC, Peng  RD.  Urban residence, neighborhood poverty, race/ethnicity, and asthma morbidity among children on Medicaid.   J Allergy Clin Immunol. 2017;140(3):822-827. doi:10.1016/j.jaci.2017.01.036PubMedGoogle ScholarCrossref
29.
Tamimi  A, Serdarevic  D, Hanania  NA.  The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.   Respir Med. 2012;106(3):319-328. doi:10.1016/j.rmed.2011.11.003PubMedGoogle ScholarCrossref
30.
Marquette  CH, Saulnier  F, Leroy  O,  et al.  Long-term prognosis of near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma.   Am Rev Respir Dis. 1992;146(1):76-81. doi:10.1164/ajrccm/146.1.76PubMedGoogle ScholarCrossref
31.
Ulrik  CS, Frederiksen  J.  Mortality and markers of risk of asthma death among 1,075 outpatients with asthma.   Chest. 1995;108(1):10-15. doi:10.1378/chest.108.1.10PubMedGoogle ScholarCrossref
32.
Mitchell  I, Tough  SC, Semple  LK, Green  FH, Hessel  PA.  Near-fatal asthma: a population-based study of risk factors.   Chest. 2002;121(5):1407-1413. doi:10.1378/chest.121.5.1407PubMedGoogle ScholarCrossref
33.
Osborne  ML, Pedula  KL, O’Hollaren  M,  et al.  Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study.   Chest. 2007;132(4):1151-1161. doi:10.1378/chest.05-3084PubMedGoogle ScholarCrossref
34.
Scanlon  PD, Connett  JE, Waller  LA,  et al; Lung Health Study Research Group.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study.   Am J Respir Crit Care Med. 2000;161(2 Pt 1):381-390. doi:10.1164/ajrccm.161.2.9901044PubMedGoogle Scholar
35.
Anthonisen  NR, Skeans  MA, Wise  RA, Manfreda  J, Kanner  RE, Connett  JE; Lung Health Study Research Group.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.   Ann Intern Med. 2005;142(4):233-239. doi:10.7326/0003-4819-142-4-200502150-00005PubMedGoogle ScholarCrossref
36.
National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health.  The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention. 2014.
37.
Jarvis  D, Chinn  S, Luczynska  C, Burney  P.  Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances.   Lancet. 1996;347(8999):426-431. doi:10.1016/S0140-6736(96)90009-4PubMedGoogle ScholarCrossref
38.
Belanger  K, Triche  EW.  Indoor combustion and asthma.   Immunol Allergy Clin North Am. 2008;28(3):507-519, vii. doi:10.1016/j.iac.2008.03.011PubMedGoogle ScholarCrossref
39.
Zhou  Y, Zou  Y, Li  X,  et al.  Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study.   PLoS Med. 2014;11(3):e1001621. doi:10.1371/journal.pmed.1001621PubMedGoogle Scholar
40.
Lahiri  K, Pulungan  Z. Income-related health disparity and its determinants in New York state: racial/ethnic and geographical comparisons. In: Wallace  BC, ed.  Toward Equity in Health: A New Global Approach to Health Disparities. Springer; 2007.
41.
Arndt  S, Acion  L, Caspers  K, Blood  P.  How reliable are county and regional health rankings?   Prev Sci. 2013;14(5):497-502. doi:10.1007/s11121-012-0320-3PubMedGoogle ScholarCrossref
Original Investigation
Public Health
November 29, 2021

Association of Chronic Lower Respiratory Disease With County Health Disparities in New York State

Author Affiliations
  • 1Department of Medicine, University at Buffalo–Catholic Health System, Buffalo, New York
  • 2Division of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
  • 3Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York
JAMA Netw Open. 2021;4(11):e2134268. doi:10.1001/jamanetworkopen.2021.34268
Key Points

Question  Are county-level health disparities associated with chronic lower respiratory disease (CLRD) outcomes in New York state?

Findings  In this cross-sectional study including 60 335 CLRD hospitalizations and 20 612 CLRD deaths in 62 counties in New York state, county-level health indicators as assessed by County Health Rankings were significantly associated with CLRD hospitalization and mortality rates.

Meaning  These findings suggest that public health interventions and resources aimed at improving CLRD outcomes should be tailored and prioritized in health disadvantaged areas.

Abstract

Importance  Chronic lower respiratory disease (CLRD) is the fourth leading cause of death in the United States, which imposes a considerable burden on individuals, families, and societies. The association between county-level health disparity and CLRD outcomes in New York state needs investigation.

Objective  To evaluate the associations of CLRD outcomes with county-level health disparities in New York state.

Design, Setting, and Participants  In this cross-sectional study, CLRD age-adjusted hospitalization for 2016 and mortality rates from 2014 to 2016 were obtained from the New York state Community Health Indicator Reports provided by the New York state Department of Health. County Health Rankings were used to evaluate various health factors to provide a summary z score for each county representing the county health status and how that county ranks in the state. Data analysis was performed from November 2020 to March 2021.

Main Outcomes and Measures  The main outcomes were age-adjusted hospitalization and mortality rates for CLRD. The z score was calculated from the County Health Rankings, which includes subindicators of health behaviors, clinical care, social and economic factors, and physical environment. Pearson r and linear regression models were estimated.

Results  During the study, 60 335 discharges were documented as CLRD hospitalizations in 2016 and 20 612 people died from CLRD from 2014 to 2016 in New York state. After adjusting for age, the CLRD hospitalization rate was 27.6 per 10 000 population, and the mortality rate was 28.9 per 100 000 population. Among 62 counties, Bronx had the highest hospitalization rate (64.7 per 10 000 population) whereas Hamilton had the lowest hospitalization rate (6.6 per 10 000 population). Mortality rates ranged from 17.4 per 100 000 population in Kings to 62.9 per 100 000 population in Allegany. County Health Rankings indicated Nassau had the lowest z score (the healthiest), at −1.17, but Bronx had the highest z score (the least healthy), at 1.43, for overall health factors in 2018. An increase of 1 point in social and economic factors z score was associated with an increase of 17.6 hospitalizations per 10 000 population (β = 17.61 [95% CI, 10.36 to 24.87]; P < .001). A 1-point increase in health behaviors z score was associated with an increase of 41.4 deaths per 100 000 population (β = 41.42 [95% CI, 29.88 to 52.97]; P < .001).

Conclusions and Relevance  In this cross-sectional study, CLRD outcomes were significantly associated with county-level health disparities in New York state. These findings suggest that public health interventions and resources aimed at improving CLRD outcomes should be tailored and prioritized in health disadvantaged areas.

Introduction

Chronic lower respiratory disease (CLRD) is defined by the Centers for Disease Control and Prevention (CDC) and the World Health Organization as encompassing 4 major diseases: chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, and asthma.1-3 In the United States, approximately 14.8 million people have been diagnosed with COPD and more than 25 million people have asthma.4,5 According to the CDC, CLRD has resulted in 47.8 deaths per 100 000 population, making it the fourth leading cause of death in 2019.6 As a major public health issue, CLRD imposes a considerable burden on individuals, families, and societies. In 2008, the direct cost for health care expenditures related to CLRD was estimated at $53.7 billion and the indirect cost due to lost productivity was estimated at $14.3 billion.4

Health behaviors and social determinants of health have been identified as the most important modifiable risk factors associated with CLRD, which include tobacco smoking, indoor and outdoor air pollution, exposure to allergens and occupational agents, unhealthy diet, obesity, and physical inactivity.7 Even though several studies clearly indicated socioeconomic status (SES) and health disparities could contribute to CLRD outcomes at regional or national level, to our knowledge, no study has investigated the association between county-level health disparity and CLRD outcomes in New York state. In this study, we hypothesized that CLRD hospitalizations and mortality would be significantly correlated with overall county health status and county-level health indicators. Our aim was to examine and provide a general overview of the association between CLRD outcomes and health disparities in New York state.

Methods

This cross-sectional study was deemed exempt from review and informed consent by the University at Buffalo institutional review board because this study only involved analysis of deidentified data in the public domain. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

Data Resources and Study Design

The CLRD age-adjusted hospitalization rates per 10 000 population for 2016 and mortality rates per 100 000 population for 2014 to 2016 were obtained from the New York state Community Health Indicator Reports provided by the New York State Department of Health. The International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)8 codes used for CLRD are codes J40-J47. The standard population used for age adjustment was the 2000 US population.

The County Health Rankings (CHR) program was created as a collaboration between the Robert Wood Johnson Foundation and the University of Wisconsin Population Health Institute. The CHR evaluates various health factors to provide a summary score for each county representing how that county ranks in the state. The county overall health factors rankings are calculated based on a weighted sum of z scores for each health factor in 4 categories: 30% for health behaviors (ie, tobacco use, diet and exercise, alcohol and drug use, and sexual activity), 20% for clinical care (ie, access to care and quality of care), 40% for social and economic factors (ie, education, employment, income, family and social support, and community safety), and 10% for physical environment (ie, air and water quality, housing, and transit). The choice to determine weights for each of the measures was based on its relative importance and guided by 5 perspectives, including historical perspective, review of the literature, weighting schemes used by other health rankings, analytic approach, and pragmatic approach involving stakeholder engagement.9,10 The CHR data are gathered from existing surveillance methods, such as the Behavioral Risk Factor Surveillance System, CDC, National Center for Health Statistics, US Department of Education, Bureau of Labor Statistics, and American Community Survey.9,10 We used the CHR data for New York state in 2018, which covers 2012 to 2016. The overall heath factors rankings z score and each category z score for health behaviors, clinical care, social and economic factors, and physical environment were examined in the present study.

Statistical Analysis

We calculated the correlations between county-level health factors z scores and CLRD hospitalization and mortality rates using Pearson r. Univariable (UVA) and multivariable linear regression analyses (MVA) were used to determine the associations between county-level health factors z score and CLRD hospitalization and mortality rates. Any variables reported in UVA as significantly associated with CLRD outcomes or found to be strongly correlated in the preliminary analyses (Pearson r > 0.3 or r < −0.3) were then included in the multivariable linear regression model. All data management and statistical analyses were performed in Excel spreadsheets (Microsoft) and SAS statistical software version X.X (SAS Institute). P < .05 using 2-sided t tests were considered statistically significant. Data analysis was performed from November 2020 to March 2021.

Results
CLRD Hospitalization and Mortality Rates by County in New York State

We first examined CLRD statistics in the New York state by analyzing the age-adjusted hospitalization rates in 2016 and mortality rates from 2014 to 2016. During this period, a total of 60 335 discharges were documented as CLRD hospitalizations and 20 612 people died from CLRD in New York state. The overall age-adjusted hospitalization rate was 27.6 per 10 000 population and the overall CLRD mortality rate was 28.9 per 100 000. The analysis based on 62 counties in New York state indicated that Bronx had the highest age-adjusted hospitalization rate (64.7 per 10 000 population) whereas Hamilton had the lowest hospitalization rate (6.6 per 10 000 population). Age-adjusted mortality rates ranged from 17.4 per 100 000 population in Kings to 62.9 per 100 000 population in Allegany. The results are summarized in Table 1 and shown in Figure 1 and Figure 2.

Association Between County Heath Factors z Score and CLRD Hospitalization and Mortality Rates

Table 1 and Figure 3 show the CHR health factors z score for 62 counties in 5 different categories: overall health factors, health behaviors, clinical care, social and economic factors, and physical environment. Among 62 counties, Nassau had the lowest z score (the healthiest) for both overall health factors (z = −1.17) and health behaviors (z = −0.49) and Bronx had the highest z score (the least healthy) for overall health factors (z = 1.43), clinical care (z = 0.25), and social and economic factors (z = 1.04).

In Pearson correlation and UVA, counties with higher z score of overall health factors (r = 0.51; P < .001), clinical care (r = 0.33; P = .008), social and economic factors (r = 0.54; P < .001), and physical environment (r = 0.29; P = .02) were correlated with higher CLRD hospitalization rate; given the result of UVA and Pearson correlation, the variables of clinical care, social and economic factors, and physical environment were added to the MVA model, and only social and economic factors (β = 17.61 [95% CI, 10.36 to 24.87]; P < .001) and physical environment (β = 82.78 [95% CI, 36.94 to 128.63]; P < .001) remained independently associated in MVA (R2 = 0.431). An increase of 1 point of z score in social and economic factors was associated with an increase of 17.6 hospitalizations per 10 000 population, and a 1-point increase physical environment was associated with an increase of 82.8 hospitalizations per 10 000 population. Regarding the association between health factors and CLRD mortality rate, counties with higher z score of overall health factors (r = 0.45; P < .001) and health behaviors (r = 0.71; P < .001) were correlated with higher mortality rate, whereas an opposite association was found in physical environment (r = −0.35; P = .005). In the MVA model with variables of health behaviors and physical environment, a 1-point increase in z score of health behaviors was associated with an increase of 41.4 deaths per 100 000 population (β = 41.42 [95% CI, 29.88 to 52.97]; P < .001), and a 1-point increase in physical environment was associated with a decrease of 63.4 deaths per 100 000 population (β = −63.40 [95% CI, −123.86 to −2.94]; P = .04; R2 = 0.532). Table 2 summarized the analysis results. We performed an MVA to examine the association between each subfactor of physical environment and CLRD mortality and found that counties with a higher percentage of severe housing problems were significantly associated with lower CLRD mortality (β = −5.92; P = .002).

Discussion

This cross-sectional study is the first study, to our knowledge, to assess the associations between county-level health factors and CLRD hospitalization and mortality rates in New York state. This study found geographic differences in CLRD outcomes among counties and their associations with county-level health disparities. The mapping of CLRD hospitalization and mortality rates shows the different distribution in New York state. The highest hospitalization rate was found in New York City (Bronx, Kings, New York, Queens, and Richmond counties), whereas the lowest was in North Country (Clinton, Essex, Franklin, Hamilton, Warren, and Washington counties) and Southern Tier (Broome, Chenango, Delaware, Tioga, and Tompkins counties). For mortality, the highest rate was seen in Western New York (Allegany, Cattaraugus, Chautauqua, Erie, Genesee, Niagara, Orleans, and Wyoming counties) and North Country, but the lowest was in New York City.

CLRD hospitalization and mortality rates are associated with cigarette smoking and socioeconomic status (eg, income, education, occupation, respiratory tract infections, air pollution, and housing conditions).11-23 This study found a positive association between overall CHR health factors and CLRD outcomes, indicating higher hospitalization and mortality rates in counties with worse health status. Previous studies have found that SES disparity was associated with the risk of hospitalizations for asthma or COPD. A 2014 study by Trachtenberg et al24 reported that patients with CLRD in the lowest income quintile were approximately 3-fold more likely to be hospitalized than those in the highest income quintile. Similarly, studies by Calderón-Larrañaga et al,25 McAllister et al,26 and Gupta et al27 all found a significant association between Index of Multiple Deprivation score, an SES measure using multiple domains (eg, income, housing, access, education), and hospitalizations for asthma and COPD, suggesting lower SES was associated with higher risk of hospitalizations. Interestingly, a 2017 study by Keet et al28 also suggested residence in urban or poor areas was an important risk factor for asthma-related emergency department visits and hospitalizations.28 These findings are generally consistent with our study result as overall CHR health factors, social and economic factors, and physical environment had significant associations with CLRD hospitalizations in New York state.

Cigarette smoking is a modifiable health-related behavior and is associated with accelerated decline of lung function and higher mortality rates for asthma and COPD.29 Previous research identified cigarette smoking as a leading risk factor of increased numbers of life threatening asthma attacks and greater asthma mortality.30-33 A study by Marquette et al30 reported that the odds of mortality were 3.6-fold in smokers with asthma compared with nonsmokers with asthma. Smoking cessation is an essential intervention in the treatment of COPD to slow the progressive decline in lung function as well as improve survival in COPD. In the Lung Health Study,34,35 5587 smokers with mild to moderate COPD were randomized to smoking cessation or usual care, and after 14.5 years of follow-up, those who quit smoking had better lung function and a lower mortality rate. Likewise, the 2014 Surgeon General’s Report indicated nearly 8 out of 10 COPD-related deaths were a result of smoking.36 All these findings can be the reason that overall CHR health factors and health behaviors were strongly associated with CLRD mortality in New York state.

A surprising and unexpected finding was the paradoxical association between the physical environment indicator and CLRD mortality. The negative association was not consistent with our expectation that better physical environments would improve health outcomes. Therefore, we performed an MVA to examine the association between each subfactor of physical environment and CLRD mortality. The analysis showed counties with higher percentage of severe housing problems were significantly associated with lower CLRD mortality. Lack of a kitchen is one of the main components of severe housing problems, and that could be an explanation for this finding, as several studies suggested exposure to indoor combustion and cooking fuels may increase the risk of asthma and COPD and associated outcomes.37-39

The CHR is a program to evaluate multiple factors that can impact health disparities and determine the health status of counties in the state. The reliability and accuracy of CHR are important to consider for describing patterns across a state. A report by Lahiri et al40 found that North Country in upstate New York and Bronx county in downstate New York both have the worst quality of health and income-related health inequality, suggesting areas with lower quality of health have larger health disparities between the rich and the poor in New York state. These geographic findings are similar to CHR data for New York state. A study by Arndt et al41 also found an interesting negative correlation between reliability of CHR measures and number of counties in a state, suggesting that New York state, with 62 counties, may have higher reliability in the CHR measures. Therefore, CHR could be considered a reliable measure to characterize the county health status in New York state.

Limitations

There are some limitations to our study. The standardized manner of data collection using population-based surveillance to examine CLRD outcomes and county-level health indicators in New York state is a strength. However, the hospitalization data are based on diagnosis ICD-10-CM codes8 from the hospital data system, and mortality data are based on death certificates from Vital Statistics of New York State Department of Health. There are intrinsic limitations and concerns related to the potential for inconsistent reports leading to misclassification and incorrect coding of diagnoses by physicians in the data set. Using indicators from CHR to represent the health disparities among counties in New York state is another limitation and may not be specific. The data of CHR indicators included in the annual rankings may be from different time frames, such as Behavioral Risk Factor Surveillance System data from 2016 and American Community Survey data from 2012 to 2016 in the 2018 CHR report. Another important limitation in this study is the ecological fallacy, since associations on population levels may not reflect associations on individual levels. Therefore, these results must be interpreted with caution, and further studies are suggested to support our findings.

Conclusions

This cross-sectional study found a remarkable variation on CLRD hospitalization and mortality rates in New York state. CLRD outcomes were significantly associated with county-level health disparities. These findings suggested that public health interventions and resources aimed at improving CLRD outcomes should be tailored and prioritized in health disadvantaged areas.

Back to top
Article Information

Accepted for Publication: September 16, 2021.

Published: November 29, 2021. doi:10.1001/jamanetworkopen.2021.34268

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Lee YC et al. JAMA Network Open.

Corresponding Author: Yu-Che Lee, MD, MPH, Department of Medicine, University at Buffalo-Catholic Health System, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, 2157 Main St, Buffalo, NY 14214 (yuchelee@buffalo.edu).

Author Contributions: Dr Lee had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Lee, Chang.

Acquisition, analysis, or interpretation of data: Lee, Sethi.

Drafting of the manuscript: Lee, Chang.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Lee.

Administrative, technical, or material support: Lee, Chang.

Supervision: Lee, Sethi.

Conflict of Interest Disclosures: None reported.

References
1.
Vestbo  J, Hurd  SS, Agustí  AG,  et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.   Am J Respir Crit Care Med. 2013;187(4):347-365. doi:10.1164/rccm.201204-0596PPPubMedGoogle ScholarCrossref
2.
Postma  DS, Rabe  KF.  The asthma–COPD overlap syndrome.   N Engl J Med. 2015;373(13):1241-1249. doi:10.1056/NEJMra1411863PubMedGoogle ScholarCrossref
3.
Cloutier  MM, Baptist  AP, Blake  KV,  et al; Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC).  2020 focused updates to the asthma management guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.   J Allergy Clin Immunol. 2020;146(6):1217-1270. doi:10.1016/j.jaci.2020.10.003PubMedGoogle ScholarCrossref
4.
National Heart, Lung, and Blood Institute (NHLBI).  Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung and Blood Diseases. National Institutes of Health; 2012.
5.
Blackwell  DL, Lucas  JW, Clarke  TC.  Summary health statistics for U.S. adults: national health interview survey, 2012.   Vital Health Stat 10. 2014;(260):1-161.PubMedGoogle Scholar
6.
Centers for Disease Control and Prevention. Underlying cause of death, 1999-2019. Accessed October 28, 2021. https://wonder.cdc.gov/ucd-icd10.html
7.
Global Alliance Against Chronic Respiratory Diseases. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Accessed October 28, 2021. https://www.who.int/gard/publications/GARD_Manual/en/
8.
Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Accessed October 28, 2021. https://www.cdc.gov/nchs/icd/icd10cm.htm
9.
Booske  BC, Athens  JK, Kindig  DA, Park  H, Remington  PL.  County Health Rankings Working Paper: Different Perspectives for Assigning Weights to Determinants of Health. University of Wisconsin; 2012.
10.
Remington  PL, Catlin  BB, Gennuso  KP.  The County Health Rankings: rationale and methods.   Popul Health Metr. 2015;13(1):11. doi:10.1186/s12963-015-0044-2PubMedGoogle ScholarCrossref
11.
Pleasants  RA, Riley  IL, Mannino  DM.  Defining and targeting health disparities in chronic obstructive pulmonary disease.   Int J Chron Obstruct Pulmon Dis. 2016;11:2475-2496. doi:10.2147/COPD.S79077PubMedGoogle ScholarCrossref
12.
Prescott  E, Godtfredsen  N, Vestbo  J, Osler  M.  Social position and mortality from respiratory diseases in males and females.   Eur Respir J. 2003;21(5):821-826. doi:10.1183/09031936.03.00047502PubMedGoogle ScholarCrossref
13.
Steenland  K, Hu  S, Walker  J.  All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997.   Am J Public Health. 2004;94(6):1037-1042. doi:10.2105/AJPH.94.6.1037PubMedGoogle ScholarCrossref
14.
Huisman  M, Kunst  AE, Bopp  M,  et al.  Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations.   Lancet. 2005;365(9458):493-500. doi:10.1016/S0140-6736(05)17867-2PubMedGoogle ScholarCrossref
15.
Lewis  DR, Clegg  LX, Johnson  NJ.  Lung disease mortality in the United States: the national longitudinal mortality study.   Int J Tuberc Lung Dis. 2009;13(8):1008-1014.PubMedGoogle Scholar
16.
Gershon  AS, Hwee  J, Victor  JC, Wilton  AS, To  T.  Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease.   Ann Am Thorac Soc. 2014;11(8):1195-1202. doi:10.1513/AnnalsATS.201403-094OCPubMedGoogle ScholarCrossref
17.
Sullivan  K, Thakur  N.  Structural and social determinants of health in asthma in developed economies: a scoping review of literature published between 2014 and 2019.   Curr Allergy Asthma Rep. 2020;20(2):5. doi:10.1007/s11882-020-0899-6PubMedGoogle ScholarCrossref
18.
McLeish  AC, Zvolensky  MJ.  Asthma and cigarette smoking: a review of the empirical literature.   J Asthma. 2010;47(4):345-361. doi:10.3109/02770900903556413PubMedGoogle ScholarCrossref
19.
Polosa  R, Thomson  NC.  Smoking and asthma: dangerous liaisons.   Eur Respir J. 2013;41(3):716-726. doi:10.1183/09031936.00073312PubMedGoogle ScholarCrossref
20.
Godtfredsen  NS, Lam  TH, Hansel  TT,  et al.  COPD-related morbidity and mortality after smoking cessation: status of the evidence.   Eur Respir J. 2008;32(4):844-853. doi:10.1183/09031936.00160007PubMedGoogle ScholarCrossref
21.
Berry  CE, Wise  RA.  Mortality in COPD: causes, risk factors, and prevention.   COPD. 2010;7(5):375-382. doi:10.3109/15412555.2010.510160PubMedGoogle ScholarCrossref
22.
Celli  BR.  Predictors of mortality in COPD.   Respir Med. 2010;104(6):773-779. doi:10.1016/j.rmed.2009.12.017PubMedGoogle ScholarCrossref
23.
Tønnesen  P.  Smoking cessation and COPD.   Eur Respir Rev. 2013;22(127):37-43. doi:10.1183/09059180.00007212PubMedGoogle ScholarCrossref
24.
Trachtenberg  AJ, Dik  N, Chateau  D, Katz  A.  Inequities in ambulatory care and the relationship between socioeconomic status and respiratory hospitalizations: a population-based study of a Canadian city.   Ann Fam Med. 2014;12(5):402-407. doi:10.1370/afm.1683PubMedGoogle ScholarCrossref
25.
Calderón-Larrañaga  A, Carney  L, Soljak  M,  et al.  Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England: national cross-sectional study.   Thorax. 2011;66(3):191-196. doi:10.1136/thx.2010.147058PubMedGoogle ScholarCrossref
26.
McAllister  DA, Morling  JR, Fischbacher  CM, MacNee  W, Wild  SH.  Socioeconomic deprivation increases the effect of winter on admissions to hospital with COPD: retrospective analysis of 10 years of national hospitalisation data.   Prim Care Respir J. 2013;22(3):296-299. doi:10.4104/pcrj.2013.00066PubMedGoogle ScholarCrossref
27.
Gupta  RP, Mukherjee  M, Sheikh  A, Strachan  DP.  Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England.   Thorax. 2018;73(8):706-712. doi:10.1136/thoraxjnl-2017-210714PubMedGoogle ScholarCrossref
28.
Keet  CA, Matsui  EC, McCormack  MC, Peng  RD.  Urban residence, neighborhood poverty, race/ethnicity, and asthma morbidity among children on Medicaid.   J Allergy Clin Immunol. 2017;140(3):822-827. doi:10.1016/j.jaci.2017.01.036PubMedGoogle ScholarCrossref
29.
Tamimi  A, Serdarevic  D, Hanania  NA.  The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.   Respir Med. 2012;106(3):319-328. doi:10.1016/j.rmed.2011.11.003PubMedGoogle ScholarCrossref
30.
Marquette  CH, Saulnier  F, Leroy  O,  et al.  Long-term prognosis of near-fatal asthma: a 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma.   Am Rev Respir Dis. 1992;146(1):76-81. doi:10.1164/ajrccm/146.1.76PubMedGoogle ScholarCrossref
31.
Ulrik  CS, Frederiksen  J.  Mortality and markers of risk of asthma death among 1,075 outpatients with asthma.   Chest. 1995;108(1):10-15. doi:10.1378/chest.108.1.10PubMedGoogle ScholarCrossref
32.
Mitchell  I, Tough  SC, Semple  LK, Green  FH, Hessel  PA.  Near-fatal asthma: a population-based study of risk factors.   Chest. 2002;121(5):1407-1413. doi:10.1378/chest.121.5.1407PubMedGoogle ScholarCrossref
33.
Osborne  ML, Pedula  KL, O’Hollaren  M,  et al.  Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study.   Chest. 2007;132(4):1151-1161. doi:10.1378/chest.05-3084PubMedGoogle ScholarCrossref
34.
Scanlon  PD, Connett  JE, Waller  LA,  et al; Lung Health Study Research Group.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study.   Am J Respir Crit Care Med. 2000;161(2 Pt 1):381-390. doi:10.1164/ajrccm.161.2.9901044PubMedGoogle Scholar
35.
Anthonisen  NR, Skeans  MA, Wise  RA, Manfreda  J, Kanner  RE, Connett  JE; Lung Health Study Research Group.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.   Ann Intern Med. 2005;142(4):233-239. doi:10.7326/0003-4819-142-4-200502150-00005PubMedGoogle ScholarCrossref
36.
National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health.  The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention. 2014.
37.
Jarvis  D, Chinn  S, Luczynska  C, Burney  P.  Association of respiratory symptoms and lung function in young adults with use of domestic gas appliances.   Lancet. 1996;347(8999):426-431. doi:10.1016/S0140-6736(96)90009-4PubMedGoogle ScholarCrossref
38.
Belanger  K, Triche  EW.  Indoor combustion and asthma.   Immunol Allergy Clin North Am. 2008;28(3):507-519, vii. doi:10.1016/j.iac.2008.03.011PubMedGoogle ScholarCrossref
39.
Zhou  Y, Zou  Y, Li  X,  et al.  Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study.   PLoS Med. 2014;11(3):e1001621. doi:10.1371/journal.pmed.1001621PubMedGoogle Scholar
40.
Lahiri  K, Pulungan  Z. Income-related health disparity and its determinants in New York state: racial/ethnic and geographical comparisons. In: Wallace  BC, ed.  Toward Equity in Health: A New Global Approach to Health Disparities. Springer; 2007.
41.
Arndt  S, Acion  L, Caspers  K, Blood  P.  How reliable are county and regional health rankings?   Prev Sci. 2013;14(5):497-502. doi:10.1007/s11121-012-0320-3PubMedGoogle ScholarCrossref
×